First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study

Hypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity. The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the meta...

Full description

Bibliographic Details
Main Authors: Marie Austdal, Line H. Tangerås, Ragnhild B. Skråstad, Kjell Salvesen, Rigmor Austgulen, Ann-Charlotte Iversen, Tone F. Bathen
Format: Article
Language:English
Published: MDPI AG 2015-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:http://www.mdpi.com/1422-0067/16/9/21520
id doaj-14fcc3a405ef4953a1ef068e22e05bb7
record_format Article
spelling doaj-14fcc3a405ef4953a1ef068e22e05bb72020-11-25T01:44:04ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-09-01169215202153810.3390/ijms160921520ijms160921520First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening StudyMarie Austdal0Line H. Tangerås1Ragnhild B. Skråstad2Kjell Salvesen3Rigmor Austgulen4Ann-Charlotte Iversen5Tone F. Bathen6Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwaySt. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, NorwayDepartment of Laboratory Medicine Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayNational Center for Fetal Medicine, Department of Obstetrics and Gynecology, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, NorwayCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayDepartment of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, 7491 Trondheim, NorwayHypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity. The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the metabolic changes related to the diseases. Metabolic profiles were obtained by nuclear magnetic resonance spectroscopy of serum and urine samples from 599 women at medium to high risk of preeclampsia (nulliparous or previous preeclampsia/gestational hypertension). Preeclampsia developed in 26 (4.3%) and gestational hypertension in 21 (3.5%) women. Multivariate analyses of the metabolic profiles were performed to establish prediction models for the hypertensive disorders individually and combined. Urinary metabolomic profiles predicted preeclampsia and gestational hypertension at 51.3% and 40% sensitivity, respectively, at 10% false positive rate, with hippurate as the most important metabolite for the prediction. Serum metabolomic profiles predicted preeclampsia and gestational hypertension at 15% and 33% sensitivity, respectively, with increased lipid levels and an atherogenic lipid profile as most important for the prediction. Combining maternal characteristics with the urinary hippurate/creatinine level improved the prediction rates of preeclampsia in a logistic regression model. The study indicates a potential future role of clinical importance for metabolomic analysis of urine in prediction of preeclampsia.http://www.mdpi.com/1422-0067/16/9/21520NMR spectroscopypreeclampsiametabolomicsPLS-DAgestational hypertensionpredictionfirst-trimester screeningbiomarker
collection DOAJ
language English
format Article
sources DOAJ
author Marie Austdal
Line H. Tangerås
Ragnhild B. Skråstad
Kjell Salvesen
Rigmor Austgulen
Ann-Charlotte Iversen
Tone F. Bathen
spellingShingle Marie Austdal
Line H. Tangerås
Ragnhild B. Skråstad
Kjell Salvesen
Rigmor Austgulen
Ann-Charlotte Iversen
Tone F. Bathen
First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
International Journal of Molecular Sciences
NMR spectroscopy
preeclampsia
metabolomics
PLS-DA
gestational hypertension
prediction
first-trimester screening
biomarker
author_facet Marie Austdal
Line H. Tangerås
Ragnhild B. Skråstad
Kjell Salvesen
Rigmor Austgulen
Ann-Charlotte Iversen
Tone F. Bathen
author_sort Marie Austdal
title First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
title_short First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
title_full First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
title_fullStr First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
title_full_unstemmed First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
title_sort first trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2015-09-01
description Hypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal morbidity. The goal of this study was to evaluate the potential of metabolomics to predict preeclampsia and gestational hypertension from urine and serum samples in early pregnancy, and elucidate the metabolic changes related to the diseases. Metabolic profiles were obtained by nuclear magnetic resonance spectroscopy of serum and urine samples from 599 women at medium to high risk of preeclampsia (nulliparous or previous preeclampsia/gestational hypertension). Preeclampsia developed in 26 (4.3%) and gestational hypertension in 21 (3.5%) women. Multivariate analyses of the metabolic profiles were performed to establish prediction models for the hypertensive disorders individually and combined. Urinary metabolomic profiles predicted preeclampsia and gestational hypertension at 51.3% and 40% sensitivity, respectively, at 10% false positive rate, with hippurate as the most important metabolite for the prediction. Serum metabolomic profiles predicted preeclampsia and gestational hypertension at 15% and 33% sensitivity, respectively, with increased lipid levels and an atherogenic lipid profile as most important for the prediction. Combining maternal characteristics with the urinary hippurate/creatinine level improved the prediction rates of preeclampsia in a logistic regression model. The study indicates a potential future role of clinical importance for metabolomic analysis of urine in prediction of preeclampsia.
topic NMR spectroscopy
preeclampsia
metabolomics
PLS-DA
gestational hypertension
prediction
first-trimester screening
biomarker
url http://www.mdpi.com/1422-0067/16/9/21520
work_keys_str_mv AT marieaustdal firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
AT linehtangeras firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
AT ragnhildbskrastad firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
AT kjellsalvesen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
AT rigmoraustgulen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
AT anncharlotteiversen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
AT tonefbathen firsttrimesterurineandserummetabolomicsforpredictionofpreeclampsiaandgestationalhypertensionaprospectivescreeningstudy
_version_ 1725030151079591936